Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/27/07 → 7/31/09 |
Funding
- UCB Pharma (domestic): $51,315.00
An International, Double-Blind, Parallel-Group, Placebo-Controlled, Randomized Study: Evaluation of the Efficacy and Safety of Brivaracetam in Subjects (16 to 70 years old) with Partial Onset Seizures
- Fakhoury, Toufic (PI)
- Bensalem Owen, Meriem (CoI)